Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Share News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bioquell surges on offer from Bill Gates-backed Ecolab

Fri, 30th Nov 2018 08:49

(Sharecast News) - Bioquell shares surged on Friday as it agreed to be bought by US hygiene company Ecolab for £140.5m.Under the terms of the offer, Bioquell shareholders will be entitled to receive 590p in cash for each of their shares. This represents a premium of about 40.5% to the closing price on Thursday and 23.1% to the three-month volume-weighted average closing price.Ecolab provides water, hygiene and energy technologies and services. It delivers comprehensive solutions and on-site services to promote safe food, maintain clean environments, optimise water and energy use and improve operational efficiencies for customers in food, healthcare, life sciences, hospitality, energy and industrial markets in more than 170 countries around the world.Bioquell, meanwhile, manufactures infection control, bioburden control and environmental filtration technology.Bioquell said in a statement that its directors, who were advised by N+1 Singer, consider the terms of the offer to be "fair and reasonable" and intend to recommend that shareholders vote in its favour at the next general meeting.Executive chairman Ian Johnson said: "As part of Ecolab, Bioquell will be able to drive faster strategic growth in both life sciences and healthcare markets leveraging Ecolab's extensive global footprint."The Bioquell directors believe the strategic fit is extremely strong and that the combination offers employees and customers a highly desirable opportunity to continue Bioquell's successful tradition."Ecolab's offer provides Bioquell shareholders with a certain cash exit at a premium to the price at which the company's shares have traded recently and is supported by Bioquell shareholders representing, in aggregate, approximately 55.10% of the existing issued ordinary share capital of Bioquell."At 0845 GMT, Bioquell shares were up 37% to 575.10p.
More News
27 Jun 2014 15:26

UK Dividends Calendar - Week Ahead

Read more
26 Jun 2014 05:11

UK Dividends Calendar - Week Ahead

Read more
25 Jun 2014 15:21

UK Dividends Calendar - Week Ahead

Read more
4 Jun 2014 05:14

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
3 Jun 2014 15:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
3 Jun 2014 05:29

UK Dividends Calendar - Week Ahead

Tuesday, June 3Read more
2 Jun 2014 13:45

UK Dividends Calendar - Week Ahead

Tuesday, June 3Read more
2 Jun 2014 05:30

UK Dividends Calendar - Week Ahead

Monday, June 2 
JPMorgan Cla

Read more
30 May 2014 14:17

UK Dividends Calendar - Week Ahead

Monday, June 2 
JPMorgan Cla

Read more
30 May 2014 05:27

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
29 May 2014 15:03

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
29 May 2014 05:26

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
28 May 2014 15:04

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
19 May 2014 07:36

UK MORNING BRIEFING: AstraZeneca Depresses FTSE 100 On Bid Rejection

LONDON (Alliance News) - UK shares have opened starkly mixed Monday, with the FTSE 100 dragged down by AstraZeneca, while the mid-cap FTSE 250 is higher.

AstraZeneca, down 13% at the open, rejected a final GBP69 billion takeover proposal from Pfizer Inc, potentially

Read more
19 May 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more

Quickpicks are a member only feature

Login to your account